Should you invest in Trxade Group (MEDS) ?
What’s up with Trxade Group?
Trxade Group (MEDS) opened at $7.60, which means the stock is up 1.79% from yesterday’s closing price of 7.80. Today, the company has a high of $8.17 and a low of $7.60. The company has a market cap of $59.43 million with a 52-week high of $11.60 and a 52-week low of $2.70.
What about the future for Trxade Group
The high forecast for Trxade Group is 4.20 while the low is 2.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Trxade Group has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy.. Based on this information MEDS seems to be a risky buy.
About Trxade Group
Trxade Group, Inc. provides an online platform for pharmaceutical purchasers. It owns and operates a business-to-business web-based marketplace focuses on the United States pharmaceutical industry. The firm operates web-based market platform that enables trade among healthcare buyers and sellers of pharmaceuticals, accessories and services. It also provides state-licensed pharmacies and buying groups in the United States with pharmaceuticals approved by the United States Food and Drug Administration; and acts as technology consultant provider that supports their programming needs and provides research on pharmaceutical pricing and shortages in acute care and retail settings. The company was founded on July 15, 2005 and is headquartered in Land O’ Lakes, FL.